CMM Doubles Staff, Lab Space
GRAND RAPIDS — The Center for Molecular Medicine has hired three medical technologists to support the expansion of the laboratory’s clinical test and genomics services offerings.
CMM staff now includes a total of eight people. The center recently doubled its lab space from 1,600 square feet to 3,300 square feet at its location on the top floor of Grand Valley State University’s Cook-DeVos Center for Health Studies. Newcomers to the CMM team include Jin He, Kyle Ingersoll and Anna VanAgtmael.
Jin He previously served as a senior lab technician at the University of Kentucky’s Department of Clinical Science. She received her bachelor’s degree in clinical medicine from Anhui Medical University in the Anhui Province of China and her master’s in molecular cell biology from the University of Kentucky. She has been published in the Molecular and Cellular Biology journal.
Ingersoll was a molecular technologist at Spectrum Health, and before that he was a research technician at Calvin College. He served as an intern and junior scientist at Assay Design and, later, as product support scientist for that organization. Ingersoll earned his bachelor’s degree in biotechnology from Ferris State University and is a board-certified laboratory specialist in molecular biology.
VanAgtmael previously worked as a medical technologist at Metro Health Hospital, where she served as a generalist in the lab. She received her bachelor’s degree in medical technology from Michigan State University and a bachelor’s degree in clinical laboratory science from Grand Valley State University. She, too, is a board-certified medical technologist.
“We are very pleased to be able to add these three talented individuals to the CMM team,” said CMM Executive Director Daniel H. Farkas. “Their capabilities, along with our expanded lab space, will help ensure CMM can meet the rising demand we are experiencing for clinical testing in cutting-edge genomics and proteomics work.”
CMM is a state-of-the-art clinical diagnostics lab that was formed a year ago as a joint venture between the Van Andel Institute and Spectrum Health. The center investigates complex diseases such as cancer, heart disease, mental illness and other conditions at the DNA, RNA and protein levels. Its services are available to diagnostics and pharmaceutical companies.